Swiss drugmaker Roche, under pressure to increase output of its antiviral drug Tamiflu as avian flu reaches Europe, said on Tuesday it would consider granting other firms licenses to make the drug.In a move that echoes schemes to make expensive HIV/AIDS treatments available in Africa, Roche said it would consider allowing companies and governments in developing nations to produce the drug in preparation for a feared bird flu pandemic.
